Institutional Repository UDD

The role of tramadol in pain management in latin america: a report by the change pain latin america advisory panel.

Show simple item record

dc.contributor.author Santos, Joao
dc.contributor.author Lech, Osvandre
dc.contributor.author Campos, Durval
dc.contributor.author Rico, Maria
dc.contributor.author Hernandez, John
dc.contributor.author Colimon, Frantz
dc.contributor.author Guerrero, Carlos
dc.contributor.author Sempertegui, Manuel
dc.contributor.author Lara, Argelia
dc.contributor.author Flores, Jose
dc.contributor.author Amescua, César
dc.contributor.author Guillen, Maria
dc.contributor.author Berenguel, Maria
dc.contributor.author Jreige, Aziza
dc.contributor.author Bonilla, Patricia
dc.date.accessioned 2018-01-11T15:14:34Z
dc.date.available 2018-01-11T15:14:34Z
dc.date.issued 2017
dc.identifier.citation Curr Med Res Opin. 2017 Sep;33(9):1615-1621
dc.identifier.uri http://hdl.handle.net/11447/1882
dc.identifier.uri http://dx.doi.org/10.1080/03007995.2017.1354821
dc.description.abstract OBJECTIVE: Change Pain Latin America (CPLA) was created to enhance chronic pain understanding and develop pain management improving strategies in this region. During its seventh meeting (August 2016), the main objective was to discuss tramadol's role in treating pain in Latin America. Furthermore, potential pain management consequences were considered, if tramadol was to become more stringently controlled. METHODS: Key topics discussed were: main indications for prescribing tramadol, its pharmacological characteristics, safety and tolerability, effects of restrictions on its availability and use, and consequent impact on pain care quality. RESULTS: The experts agreed that tramadol is used to treat a wide spectrum of non-oncological pain conditions (e.g. post-surgical, musculoskeletal, post-traumatic, neuropathic, fibromyalgia), as well as cancer pain. Its relevance when treating special patient groups (e.g. the elderly) is recognized. The main reasons for tramadol's high significance as a treatment option are: its broad efficacy, an inconspicuous safety profile and its availability, considering that access to strong analgesics - mainly controlled drugs (classical opioids) - is highly restricted in some countries. The CPLA also agreed that tramadol is well tolerated, without the safety issues associated with long-term nonsteroidal anti-inflammatory drug (NSAID) use, with fewer opioid-like side effects than classical opioids and lower abuse risk. CONCLUSIONS: In Latin America, tramadol is a valuable and frequently used medication for treating moderate to severe pain. More stringent regulations would have significant impact on its availability, especially for outpatients. This could cause regression to older and frequently inadequate pain management methods, resulting in unnecessary suffering for many Latin American patients.
dc.format.extent 7
dc.language.iso en_US
dc.publisher Taylor & Francis Online
dc.subject Latin America
dc.subject Pain management
dc.subject abuse
dc.subject prescription control
dc.subject tramadol
dc.title The role of tramadol in pain management in latin america: a report by the change pain latin america advisory panel.
dc.type Artículo


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Browse

My Account